Impregnated polyester arterial prostheses: Performance and prospects

Annals of Vascular Surgery

Volumn 13, Issue 5, 1999, Pages 509-523

  Chakfé, Nabil ^a,c   Bizonne, Sophie Cottin ^a   Beaufigeau, Marc ^a   Urban, Elisabeth ^a   Cardon, Alain ^b   Doillon, Charles ^b   Le Magnen, Jean François ^a   Durand, Bernard ^a   Kretz, Jean Georges ^a  

^a Grp Europ Rech sur les P   (France)

^b Institut des Bio Matériaux   (Canada)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALDEHYDE; COLLAGEN; CYANAMIDE; DACRON; GELATIN; GLUTARALDEHYDE; NYLON; POLYACRYLONITRILE; POLYVINYL ALCOHOL SPONGE; SEALANT;

ARTERY PROSTHESIS; ARTICLE; INSTRUMENT STERILIZATION; PRIORITY JOURNAL; PROSTHESIS MATERIAL; TREATMENT OUTCOME; VASCULAR SURGERY;

EID: 0032848709     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100169900291     Document Type: Article

References (157)

1. Voorhees AB, Jaretzki A III, Blakemore AH. The use of tubes constructed from Vinyon N cloth in bridging arterial defects. Ann Surg 1952;135:332-336.
2. Harrison JH. Synthetic materials as vascular prostheses. I. Comparative study in small vessels of Nylon, Dacron, Orion, Ivalon sponge and Teflon. Am J Surg 1958;95:3-15.
3. Harrisson JH. Synthetic materials as vascular prostheses. I. Comparative study of Nylon, Dacron, Orlon, Ivalon sponge and Teflon in large blood vessels. Am J Surg 1958;95:16-24.
4. Snyder RW, Tenney B, Guidoin R. Strength and endurance of vascular grafts. In: Kambic HE, Kantrowitz A, Sung P, eds. Vascular Graft Update: Safety and Performance. ASTM STP 898. Philadelphia: American Society for Testing and Materials, 1986, pp. 108-121.
5. Wesolowski SA, Fries CC, Karklson KE, DeBakey MC, Sawyer PN. Porosity: primary determinant of ultimate fate of synthetic vascular grafts. Surgery 1961;50:91-96.
6. Wesolowski SA, Fries CC, Hennigar G, Fox LM, Sawyer PN, Sauvage LR. Factors contributing to long-term failures in human vascular prosthetic grafts. J Cardiovasc Surg 1964; 5:544-567.
7. Wesolowski SA, Fries CC, Martinez A, McMahon JD. Arterial prosthetic materials. Ann N Y Acad Sci 1968;146:325-344.
8. Noon GP, DeBakey MC. De Bakey Dacron prosthesis and filamentous velour graft. In: Sawyer PN, Kaplitt MJ, eds. Vascular Grafts. New York: Appleton-Century Crofts, 1978;177-184.
9. Sauvage LR, Berger K, Nakagawa Y, Wood SJ, Mansfield PB. An external velour surface for porous arterial prostheses. Surgery 1971;70:940-953.
10. Chakfé N, Chaput C, Douville Y, et al. Woven velour polyester arterial grafts with polypropylene wrap: in vivo evaluation. In: Szycher M, ed. High Performance Biomaterials: A Comprehensive Guide to Medical/Pharmaceutical Applications. Lancaster, PA: Technomic Publishing, 1991, pp. 405-424.
11. Buxton BF, Wukasch DC, Martin C, Liebig WJ, Hallman GL, Cooley DA. Practical considerations in fabric vascular grafts: introduction of a new bifurcated graft. Am J Surg 1973;125:288-293.
12. Guidoin R, King M, Marois M, Martin L, Marceau D. New polyester arterial prostheses from Great Britain: an in vitro and in vivo evaluation. Ann Biomed Eng 1986;14:351-367.
13. Crawford S, DeBakey ME, Cooley DA. Clinical use of synthetic arterial substitutes in three hundred seventeen patients. Arch Surg 1958;76:261-286.
14. Yates SG, D'Sa Barros AAB, Berger K, et al. The preclotting of porous arterial prostheses. Ann Surg 1978;188:611-622.
15. Bethea MC, Reemstsma K. Graft hemostasis: an alternative to preclotting. Ann Thorac Surg 1979;27:274.
16. Snooks SJ, Croft RJ, Wagner C. How should we preclot knitted Dacron grafts? J Vasc Surg 1988;7:538-542.
17. Halpert B, De Bakey ME, Jordan GL, Henly WS. The fate of homografts and prostheses on the human aorta. Surg Gynecol Obst 1960;111:659-674.
18. Humphries AW, Hawk WA, Cuthberson AM. Arterial prosthesis of collagen-impregnated Dacron tulle. Surgery 1961; 50:947-954.
19. Bascom JU. Gelatin to prevent blood loss from knitted arterial grafts. Surgery 1961;50:504-512.
20. Wesolowski SA, Fries CC, Domingo RT, Liebig WJ, Sawyer PN. The compound prosthetic vascular graft: a pathologic survey. Surgery 1963;53:19-44.
21. Domurado D, Thomas D, Broun G. A new method for producing proteic coatings. J Biomed Mater Res 1975;9:109-110.
22. Chang TMS. Platelet-surface interaction: effect of albumin coating or heparin complexing on thrombogenic surfaces. Can J Physiol Pharmacol 1974;52:275-285.
23. Chang C, Houck J. Demonstration of the chemotactic properties of collagen (34719). Proc Soc Exp Biol Med 1970; 134:22-24.
24. Houck H, Chang C. The chemotactic properties of the products of collagenolysis (35834). Proc Soc Exp Biol Med 1971; 138:69-75.
25. Parkins WM, Koop CE, Riegel C, Vars HM, Lockwood JS. Gelatin as a plasma substitute: with particular reference to experimental hemorrhage and burn shock. Ann Surg 1943; 118:193-214.
26. Bowes JH, Cater CW. The interaction of aldehydes with collagen. Biochim Biophys Acta 1968;168:341-352.
27. Barker H, Oliver R, Grant R, Stephen L. Formaldehyde as a pre-treatment for dermal collagen heterografts. Biochem Biophys Acta 1980;632:589-597.
28. Cooke A, Oliver RF, Edward M. An in vitro cytotoxicity study of aldehyde-treated pig dermal collagen. Br J Exp Pathol 1983;64:172-176.
29. Cheung DT, Nimni ME. Mechanism of crosslinking of proteins by glutaraldehyde II. Reaction with monomeric and polymeric collagen. Connect Tiss Res 1982;10:201-216.
30. Monsan P, Puzo G, Mazarguil H. Etude du mécanisme d'établissement des liaisons glutaraldéhyde-protéines. Biochimie 1975;57:1281-1292.
31. Nimni ME, Cheung D, Strates B, Kodama M, Sheikh K. Chemically modified collagen: a natural biomaterial for tissue replacement. J Biomed Mater Res 1987;21:741-771.
32. Rasmussen KE, Albrechtsen J. Glutaraldehyde. The influence of pH, temperature, and buffering on the polymerization rate. Histochemistry 1974;38:19-26.
33. Okamura K, Chiba C, Iriyama T, et al. Antigen depressant effect of glutaraldehyde for aortic heterografts with a valve, with special reference to a concentration right fit for the preservation of grafts. Surgery 1980;87:170-176.
34. Remy MH, Poznansky MJ. Immunogenicity and antigenicity of soluble cross-linked enzyme/albumin polymers: advantage for enzyme therapy. Lancet 1978;8:68-72.
35. Speer DP, Chvapil M, Eskelson CD, Ulreich J. Biological effects of residual glutaraldehyde in glutaraldehyde-tanned collagen biomaterials. J Biomed Mater Res 1980;14:753-764.
36. Sheehan JC, Hivaka JJ. The cross-linking of gelatin using a water-soluble carbodiimide. Am J Chem Soc 1957;79: 4528-4529.
37. Baquey C, Sigot-Luizard MF, Friede J, Prud'homme RE, Guidoin RG. Radiosterilization of albuminated polyester prostheses. Biomaterials 1987;8:185-198.
38. Guidoin R, Snyder R, King M, et al. A compound arterial prosthesis: the importance of the sterilization procedure on the healing and stability of albuminated polyester grafts. Biomaterials 1985;6:122-128.
39. Guidoin R, Downs A, Verhaeghe JL, et al. Preoperative bleeding at polyester (Dacron®) arterial prosthesis implantation. Int J Artif Organs 1987;10:393-398.
40. Branchereau A, Rudondy P, Goumier JP, Espinoza JP. Etude clinique d'une prothèse aortique en Dacron tricoté impŕgné d'albumine. Ann Vasc Surg 1990;4:138-142.
41. Chakfé N, Beaufigeau M, Nicolini P, et al. Albumin-impregnated prosthetic graft for infrarenal aortic replacement: effects on the incidence and volume of perioperative blood transfusion. Ann Vasc Surg 1997;11:588-295.
42. Drury JK, Ashton TR, Cunningham JD, Maini R, Pollock JG. Experimental and clinical experience with a gelatin impregnated Dacron prosthesis. Ann Vasc Surg 1987;1: 542-547.
43. Freischlag JA, Moore WS. Expérience clinique d'une prothèse vasculaire de Dacron tricoté imprégnée de collagène. Ann Vasc Surg 1990;4:449-454.
44. Grabitz K, Sandmann W. Clinical experience with Microvel® Hemashield® prostheses. Angiol Arch 1985;9:52-54.
45. Harjola PT, Verkkala K, Ketonen P. Hemashield® double velour bifurcation graft in vascular surgery. Angiol Arch 1985;9:55-58.
46. Lorentzen JE, Nielsen OM, Buchardt-Hansen HJ. Clinical experience with collagen-impregnated velour prosthesis. A prospective study of 50 consecutive graft implantations. Angiol Archiv 1985;9:59-61.
47. Petrilli GL, Gori A, Rezzo R, Odicino M. Le protesi Microvel Hemashield nelle ricostruzioni aortoiliache. Valutazione intraoperatoria e risultati clinici su una serie di 40 casi consecutivi. Minerva Cardioangiol 1987;35:415-420.
48. Norgren L, Berggren U, Parsson H, Ribbe E, Thorne J. How does Hemashield® affect surgical technique? Clinical results in aortic reconstructions. Angiol Arch 1985;9:39-43.
49. Raithel D, Noppeney T, Schweiger H, Meister P, Kasprzak PM. Early experience with the Meadox collagen prosthesis for aorto-femoral reconstruction. Angiol Arch 1985;9:49-51.
50. Reid DB, Pollock JG. Etude prospective de 100 prothèses aortiques imprégnées de gélatine. Ann Vasc Surg 1991;5: 320-324.
51. Reigel MM, Hollier LH, Pairolero PC, Hallett JW. Early experience with a new collagen-impregnated aortic graft. Am Surg 1988;54:134-136.
52. Stegmann TH, Haverich A, Borst HG. First clinical experiences with a new collagen-impregnated Dacron-double-velour prosthesis - control of blood loss. Angiol Arch 1985; 9:33-38.
53. Lee ME, Chaux A, Kass RM, Matloff JM. Elimination of graft hemorrhage in heparinized patients with a collagen-coated Dacron prosthesis. Mount Sinai J Med 1988;55:144-146.
54. Balzer K, Werner HH, Adamek L, Müller C, Forster H, Carstensen G. Results after implantation of gelatin-impregnated bifurcated grafts. Thorac Cardiovasc Surg 1988;36:351-355.
55. Harris PL. Comparison between a new collagen-impregnated graft (Microvel® Hemashield®) and a standard velour knitted graft (Microvel®) in the management of aortic bifurcation disease. Angiol Arch 1985;9:67-72.
56. De Mol van Otterloo JCA, van Bockel JH, Ponfoort ED, van den Akker PJ, Hermans J, Terpstra JL. Randomized study on the effect of collagen impregnation of knitted Dacron® velour aortoiliac prostheses on blood loss during aortic reconstruction. Br J Surg 1991;78:288-292.
57. Becquemin JP, Halduc F, Cavillon A. Thrombogénicité chez l'homme d'une prothèse en Dacron imprégnée d'élastomère implantée en position aorto-fémorale. Ann Vasc Surg 1994;8:443-451.
58. Barral X, Gay JL, Favre JP, Gournier JP. Do collagen-impregnated knitted Dacron grafts reduce the need for transfusion in infrarenal aortic reconstructions? Ann Vasc Surg 1995;9:339-343.
59. Chakfé N, Kretz JG, Petit H, et al. Albumin-impregnated polyester vascular prosthesis for abdominal aortic surgery: an improvement? Eur J Vasc Endovasc Surg 1996;12:346-353.
60. Swartbol P, Pärsson H, Truedson L, Sjöholm A, Norgren L. Aortobifemoral surgery induces complement activation and release of interleukine-6 but not tumour necrosis factor-alpha. Cardiovasc Surg 1996;4:483-491.
61. Fischer JB, Dennis RC, Valeri R, et al. Effect of graft material on loss of erythrocytes after aortic operations. Surg Gynecol Obst 1991;173:131-136.
62. Westaby S, Parry A, Giannopoulos N, Pillai R. Replacement of the thoracic aorta with collagen-impregnated woven Dacron grafts. Early results. J Thorac Cardiovasc Surg 1993; 46:1094-1097.
63. Tolan M, Wells F, Kendall S, Wallwork J. Clinical experience with a collagen impregnated woven Dacron graft. J Cardiovasc Surg 1995;36:323-327.
64. Adachi H, Ino T, Ide H, et al. Replacement of ascending and transverse aorta using zero-porosity gelatin impregnated graft. Jap J Thorac Surg 1993;46:588-589.
65. Wooster DL, Louch RE, Krajden S. Intra-operative bacterial contamination of vascular grafts: a prospective study. Can J Surg 1985;28:407-409.
66. Tolbert TW, Brown JL. Surface powders on surgical gloves. Arch Surg 1960;115:729.
67. Kadoba K, Schoen FJ, Jonas RA. Experimental comparison of albumin-sealed and gelatin-sealed knitted Dacron conduits. Porosity control, handling, sealant resorption, and healing. J Thorac Cardiovasc Surg 1992;103:1059-1067.
68. Siverhus DJ, Schmitt DD, Edmiston CE, et al. Adherence of mucin and non-mucin-producing staphylococci to preclotted and albumin-coated velour knitted vascular grafts. Surgery 1990;107:613-619.
69. Berger HA, Laube H, Stegmann T. Incidence of infection with the use of noncoated and collagen coated Dacron prostheses in infrarenal aortic surgery. J Cardiovasc Surg 1991;32(Suppl):100.
70. De La Faye D, Legendre JM, Guidoin R, et al. Premier contact sang/prothèse artérielle. Etude de la rétention des éléments sanguins. J Chir 1984;121:253-261.
71. Shoenfeld NA, Connolly R, Ramberg K, Valeri CR, Eldrup-Jorgensen J, Callow AD. The systemic activation of platelets by Dacron® grafts. Surg Gynecol Obst 1988;166:454-457.
72. Kottke-Marchant K, Anderson J, Rabinovitch A. The platelet reactivity of vascular graft prostheses: an in vitro model to test the effect of preclotting. Biomaterials 1986;7:441-448.
73. Kalman PG, McCullough DA, Ward CA. Evacuation of microscopic air bubbles from Dacron reduces complement activation and platelet aggregation. J Vasc Surg 1990;11:591-598.
74. Legendre JM, De La Faye D, Guidoin R, King M, Lefebre C, Gosselin C. The initial blood retention properties of arterial prostheses. Res Exp Med 1986;186:185-202.
75. Harasaki H, Kiraly RJ, Nose Y. Blood-blood pump surface interaction. In: M, Szycher ed. Biocompatible Polymers, Metals, and Composites. Lancaster: Technomic, 1983;199-212.
76. Kottke-Marchant K, Anderson JM, Umemura Y, Marchant RE. Effect of albumin coating on the in vitro blood compatibility of Dacron® arterial prostheses. Biomaterials 1989; 10:147-155.
77. Bordenave L, Caix J, Basse-Cathalinat B, et al. Experimental evaluation of a gelatin-coated polyester graft used as an arterial substitute. Biomaterials 1989;10:235-242.
78. Mercier C, Bernard PJ, Piligian F, Piquet P. Collagen-impregnated grafts and platelet adhesion. Angiol Arch 1985;9:44-48.
79. Konrad P, Dougan P, Bergqvist D. Acute thrombogenicity of collagen coating of Dacron grafts: an experimental study in sheep. Eur J Vasc Surg 1992;6:67-72.
80. De Mol van Otterloo JCA, van Bockel JH, Ponfoort ED, et al. Systemic effects of collagen-impregnated aortoiliac Dacron vascular prostheses on platelet activation and fibrin formation. J Vasc Surg 1990;14:59-66.
81. Zahrani HA, Cuschieri RJ, Lowe GDO, Douglas JT, Pollock JG. Monoclonal antibody immunoassay in the study of thrombogenicity of preclotted and gelatin-impregnated aortic prostheses. Ann Vasc Surg 1989;4:248-250.
82. Beam PE, McCollum CN, Greenhalgh RM. The influence of collagen and albumin presealants on knitted Dacron grafts. Eur J Vasc Surg 1993;7:271-276.
83. Bernert M, Balzer K. Langzeitverlauf verschiedner Dacron-Bifurkationsprotheses. 5-Jahres-Ergebnisse einer prospektiv randomisierten Studie. Chirurg 1993;64:709-714.
84. Al-Khaffaf H, Charlesworth D. Albumin-coated vascular prostheses: a five-year follow-up. J Vasc Surg 1996;23:686-690.
85. Björck CG, Bergqvist D, Glimaker H, Hallstensson S, Qvarfordt P, Troëng T. Increased thrombogenicity after polymer coating: experiences with the first version of a new woven Dacron graft for aortic reconstruction. Eur J Surg 1994;160: 9-14.
86. Jonas RA, Mayer JE, Castaneda AR. Unsatisfactory clinical experience with a collagen-sealed knitted Dacron extracardiac conduit. J Cardiac Surg 1987;2:257-264.
87. Kobayashi J, Backer CL, Zales VR, Crawford SE, Muster AJ, Mavroudis C. Failure of the Hemashield extension in right ventricle-to-pulmonary artery conduits. Ann Thorac Surg 1993;56:277-281.
88. Ishikawa S, Ohtaki A, Takahashi T, et al. Non-infective high fever after replacement of thoracic aorta using collagen-impregnated Dacron prosthesis. J Cardiovasc Surg 1995;36:143-145.
89. Landau O, Haddad M, Landau M, et al. Rejection of a gelatin-impregnated Dacron graft. Cardiovasc Surg 1993;1: 389-391.
90. Yamamoto K, Noishiki Y, Mo M, et al. Disadvantages of "Gelseal graft" as a vascular prosthesis. Jpn J Thorac Surg 1993;46:762-766.
91. Yamamoto K, Noishiki Y, Mo M, Kondo J, Matsumoto A. Unusual inflammatory responses around collagen-impregnated vascular prosthesis. Artif Organs 1993;17: 1010-1016.
92. Vohra R, Drury JK, Shapiro D, Shenkin A, Pollock JG. Sealed versus unsealed knitted Dacron prostheses: a comparison of the acute phase protein response. Ann Vasc Surg 1987;1:548-551.
93. Utoh J, Miyauchi Y, Goto H, Obayashi H, Hirata T. Inflammatory reactions after vascular prosthesis implantation: a comparison of gelatin-sealed and unsealed Dacron prostheses. Surg Today 1996;26:258-261.
94. The Canadian Multicenter Hemashield Study Group. Immunologic response to collagen-impregnated vascular grafts: a randomized prospective study. J Vasc Surg 1990; 12:741-746.
95. Norgren L, Holtas S, Persson G, Ribbe E, Saxne T, Thorne J. Immune response to collagen impregnated Dacron double velour grafts for aortic and aorto-femoral reconstructions. Eur J Vasc Surg 1990;4:379-384.
96. Lacroix H, Boel K, Nevelsteen A, Suy R. Early inflammatory response to gelatin- and collagen-sealed Dacron prostheses. Ann Vasc Surg 1995;9:152-154.
97. Utoh J, Goto H, Hirata T, Hara M, Kitamura N. Postoperative inflammatory reactions to sealed Dacron prostheses: a comparison of Gelseal® and Hemashield®. J Cardiovasc Surg 1997;38:287-290.
98. Marois Y, Chakfé N, Guidoin R, et al. An albumin coated polyester arterial graft: in vivo assessment of biocompatibility and healing characteristics. Biomaterials 1996;17:3-14.
99. Guidoin R, Marois Y, Rao TJ, et al. An albumin-coated polyester arterial prosthesis made ready to anastomose: in vivo evaluation in dogs. Clin Materi 1988;3:119-131.
100. Guidoin R, Snyder R, Martin L, et al. Albumin coating of a knitted polyester arterial prosthesis. An alternative to preclotting. Ann Thorac Surg 1984;37:457-465.
101. Guidoin R, Martin L, Gosselin C, et al. Polyester prostheses as substitutes in the thoracic aorta of dogs. II. Evaluation of albuminated polyester grafts stored in ethanol. J Biomed Mater Res 1984;18:1059-1072.
102. Ben Slimane S, Guidoin R, Marceau D, et al. Albumin-coated polyester arterial prosthesis: is xenogenic albumin safe? Biomat Artif Cells Artif Org 1987;15:453-481.
103. Ben Slimane S, Guidoin R, Mourad W, Hebert J, King MW, Sigot-Luizard MF. Polyester arterial grafts impregnated with cross-linked albumin: the role of degradation of the coating in vivo. Eur Surg Res 1988;20:12-17.
104. Sigot-Luizard MF, Domurado D, Sigot M, et al. Cytocompatibility of albuminated polyester fabrics. J Biomed Mater Res 1984;18:895-909.
105. Merhi Y, Roy R, Guidoin R, Hebert J, Mourad W, Ben Slimane S. Cellular reactions to polyester arterial prostheses impregnated with cross-linked albumin: in vivo studies in mice. Biomaterials 1989;10:56-58.
106. Warocquier-Clerout R, Sigot-Luizard MF, Legendre JM. F.P.L.C. analysis of the leakage products of proteins cross-linked on Dacron® vascular prostheses. Biomaterials 1987; 8:118-123.
107. Hake U, Gabbert H, Iversen S, Jakob H, Schmiedt W, Oelert H. Healing parameters of a new albumin-coated knitted Dacron graft. Thorac Cardiovasc Surg 1991;39:208-213.
108. Chakfé N, Gasser B, Lindner V, et al. Albumin as a sealant for a polyester vascular prosthesis: its impact on the healing sequence in humans. J Cardiovasc Surg 1996;37:431-440.
109. Chakfé N, Marois Y, Guidoin R, et al. Biocompatibility and biofonctionality of a gelatin impregnated polyester arterial prosthesis. Polym Comp Polym 1993;1:229-251.
110. Guidoin R, Marceau D, Rao TJ, et al. In vitro and in vivo characterisation of an impervious polyester arterial prosthesis: the Gelseal Triaxial® graft. Biomaterials 1987;8:433-442.
111. Pasquinelli G, Freyrie A, Preda P, Curti D, D'Addato M, Laschi R. Healing of prosthetic arterial grafts. Scanning Microsc 1990;4:351-362.
112. Sottiurai VS, Sue SL, Rau DJ, Tran AB. Comparative analysis of pseudointima biogenesis in Gelseal coated Dacron knitted graft versus crimped and non-crimpred grafts. J Cardiovasc Surg 1989;30:902-909.
113. Marois Y, Chakfé N, How T, et al. Carbodiimide cross-linked gelatin, a new coating for polyester arterial prostheses. Biomaterials 1995;16:1131-1139.
114. Guidoin R, Marois Y, Deng X, et al. Can collagen-impregnated polyester arterial prostheses be recommended as blood conduits of small diameter? ASAIO J 1996;42:974-983.
115. Guidoin R, Marceau D, Couture J, et al. Collagen coatings as biological sealants for textile arterial prostheses. Biomaterials 1989;10:156-165.
116. Quinones-Baldrich WJ, Moore WS, Ziomek S, Chvapil M. Development of a leak-proof Dacron vascular prosthesis. J Vasc Surg 1986;3:895-903.
117. Ruhland D, Wigger J, Bottcher K, von Bassewitz DB. Fate of collagen following implantation of Microvel® Hemashield® grafts in dogs. Angiol Arch 1985;9:22-32.
118. Di Marzo L, Hunter WJ, Schultz RD, Risavy J. In vivo study of collagen-impregnated double velour prosthesis. Vasc Surg 1989;23:401-411.
119. Noishiki Y, Chvapil M. Healing pattern of collagen impregnated and preclotted vascular grafts in dogs. Vasc Surg 1987;21:168-174.
120. Anderson JM. Microvel® with Hemashield® vascular grafts. A preliminary report of the healing response in humans. Angiol Arch 1985;9:73-77.
121. Angelini GD, Witsenburg M, Ten Kate FJW, Hiddema PAE, Quaegebeur JM. Severe stenotic scar contracture of the Microvel Hemashield right-sided extracardiac conduit. Ann Thorac Surg 1989;48:714-716.
122. Pärsson H, Jundzill W, Johansson K, Jonung T, Norgren L. Healing characteristics of polymer coated or collagen treated Dacron grafts: an experimental porcine study. Cardiovas Surg 1994;2:242-248.
123. Granke K, Ochsner JL, McClugage SG, Zdrahal P. Analysis of graft healing in a new elastomer-coated vascular prosthesis. Cardiovasc Surg 1993;1:254-261.
124. Hirt SW, Aoki M, Demertzis S, Siclari F, Haverich A, Borst HG. Comparative in vivo study on the healing qualities of four different presealed vascular prostheses. J Vasc Surg 1993;17:538-545.
125. Moore WS, Chvapil M, Seiffert G, Keown K. Development of an infection-resistant vascular prosthesis. Arch Surg 1981;116:1403-1407.
126. Goeau-Brissoniere O, Leport C, Bacourt F, Lebrault C, Comte R, Pechere JC. Prévention des infections de prothèses artérielles par fixation de rifampicine sur une prothèse en Dacron imprégnée de gélatine. Ann Vasc Surg 1991; 5:408-412.
127. Avramovic J, Fletcher JP. Rifampicin impregnation of a protein sealed Dacron graft: an infection resistant prosthetic vascular graft. Aust N Z J Surg 1991;61:436-440.
128. Avramovic J, Fletcher JP. Prevention of prosthetic vascular graft infection by rifampicin impregnation of a protein-sealed Dacron graft in combination with parenteral cephalosporin. J Cardiovasc Surg 1992;33:70-74.
129. Lachapelle K, Graham AM, Symes JF. Antibacterial activity, antibiotic retention, and infection resistance of a rifampin-impregnated gelatin-sealed. Dacron graft. J Vasc Surg 1994;19:675-682.
130. D'Addato M, Curti T, Freyrie A, Agus GB, Bertini D, Biasi G. Prevention of early graft infection with rifampicin-bonded Gelseal grafts: a multicentre experimental study. Cardiovasc Surg 1994;2:254-258.
131. Gahtan V, Esses GE, Bandyk DF, Nelson RT, Dupont E, Mills JL. Antistaphylococcal activity of rifampin-bonded gelatin-impregnated Dacron grafts. J Surg Res 1995;58: 105-110.
132. Goeau-Brissonière O, Mercier F, Nicolas MH, et al. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft. J Vasc Surg 1994;19:739-741.
133. Sardelic F, Ao PY, Taylor DA, Fletcher JP. Prophylaxis against Staphylococcus epidermidis vascular graft infection with rifampicin-soaked, gelatin-sealed Dacron. Cardiovasc Surg 1996;4:389-392.
134. Chervu A, Moore WS, Chvapil M, Henderson T. Efficacy and duration of antistaphylococcal activity; comparing three antibiotics bonded to Dacron vascular grafts with a collagen release system. Vasc Surg 1991;22:674-679.
135. Chervu A, Moore WS, Gelabert HA, Colburn MD, Chvapil M. Prevention of graft infection by use of prostheses bonded with a rifampin/collagen release system. J Vasc Surg 1991;14:521-525.
136. Chervu A, Moore WS, Chvapil M, Henderson T. Efficacy and duration of antistaphylococcal activity comparing three antibiotics bonded to Dacron vascular grafts with a collagen release system. J Vasc Surg 1991;13:897-901.
137. Magnan PE, Seyral P, Raoult D, Branchereau A. Activité antistaphylococcique in vitro de prothèses vasculaires en Dacron collagéné traitées par la rifampicine, la vancomycine ou l'amikacine. Ann Vasc Surg 1994;8:243-247.
138. Galdbart JO, Branger C, Andreassian B, Lambert-Zechvsky N, Kitzis M. Evaluation of six antibiotics bonded to polyethylene vascular grafts sealed with three proteins. J Surg Res 1996;66:174-178.
139. Malassiney P, Goeau-Brissonière O, Ciggia M, Péchère JC. Rifampin loading of vascular grafts. J Antimicrob Chem 1996;37:1121-1129.
140. Strachan CJL, Newsom SWB, Ashton TR. The clinical use of an antibiotic-bonded graft. Eur J Vasc Surg 1991;5:627-632.
141. French BG, Chard RB, Sholler GF, Cartmill TB. Salvage of infected truncus repair using rifampicin-impregnated gelatin-sealed graft. Ann Thorac Surg 1994;57:754-755.
142. Torsello G, Sandmann W, Gehrt A, Jungblut RM. In situ replacement of infected vascular prostheses with rifampin-soaked vascular grafts: early results. J Vasc Surg 1993;17: 768-773.
143. Gupta AK, Bandyk DF, Johnson BL. In situ repair of mycotic abdominal aortic aneurysms with rifampin-bonded gelatin-impregnated Dacron grafts: a preliminary case report. J Vasc Surg 1996;24:472-476.
144. Lundell A, Bergqvist D, Lindblad B, Leide S. The acute thrombogenicity of an infection resistant rifampicin-soaked Dacron graft: an experimental study in sheep. Eur J Vasc Surg 1992;6:403-407.
145. Curti T, Pasquinelli G, Preda P, Freyrie A, Laschi R, D'Addato M. An ultrastructural and immunocytochemical analysis of human endothelial cell adhesion on coated vascular grafts. Ann Vasc Surg 1989;3:351-363.
146. Jensen N, Lindblad B, Bergqvist D. In vitro attachment of endothelial cells to different graft material. Eur Surg Res 1996;28:49-54.
147. Dalsing MC, Kevorkian M, Raper B, et al. An experimental collagen-impregnated Dacron graft: potential for endothelial seeding. Ann Vasc Surg 1989;3:127-133.
148. Shindo S, Takagi A, Whittemore AD. Improved patency of collagen-impregnated graft after in vitro autogenous endothelial cell seeding. J Vasc Surg 1987;6:325-332.
149. Vohra R, Thompson GJL, Sharma H, Walker MG. Comparison of different vascular prostheses and matrices in relation to endothelial seeding. Br J Surg 1991;78:417-420.
150. Vohra R, Thompson GJL, Sharma H, Welch M, Walker MG. In vitro adherence and kinetics studies of adult human endothelial cell seeded polytetrafluoroethylene and gelatin impregnated Dacron grafts. Eur J Vasc Surg 1991;5:93-103.
151. Raghunath K, Biswas G, Panduranga Rao K, Joseph KT, Chvapil M. Some characteristics of collagen-heparin complex. J Biomed Mater Res 1983;17:613-621.
152. Swartbol P, Norgren L. Quantitative analysis of heparin retention on heparin bonded knitted Dacron grafts after exposure to shear stress in vitro. Int Angiol 1996;15:232-235.
153. Uretzky G, Appelbaum Y, Younes H, et al. Long-term evaluation of a new selectively biodegradable vascular graft coated with polyethylene oxide-polylactic acid for ventricular conduit. An experimental study. J Thorac Cardiovasc Surg 1990;100:769-780.
154. Greisler HP, Tattersall CW, Klosak JJ, Cabusao EA, Garfield JD, Kim DU. Partially bioresorbable vascular grafts in dogs. Surgery 1991;110:645-655.
155. Bowald S, Busch C, Ericksson I. Absorbable material in vascular prostheses: a new device. Acta Chir Scand 1980; 146:391-395.
156. Cohn D, Eichai Z, Gehrson B, et al. Introducing a selectively biodegradable filament wound arterial prosthesis: a short-term implantation study. J Biomater Med Res 1992; 26:1185-1205.
157. Sasken H, Trudell L, Galetti P, Richardson P, Chu T, Nyilas E. Histopathologic characterization of tissue-material interactions in bioresorbable vascular prostheses. In: Proceedings of the 8th Annual Meeting of the Society for Biomaterials, Birmingham, 1983;82.